Neurocrine Biosciences reported $67.8M in EBIT for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Acadia Pharmaceuticals ACAD:US $ -66772000 390K
Acorda Therapeutics ACOR:US $ -27181000 6.68M
Adamas Pharmaceuticals ADMS:US -9525000 5.45M
Agios Pharmaceuticals AGIO:US $ -91222000 5K
Alexion Pharmaceuticals ALXN:US $ 816.7M 185.9M
Alnylam Pharmaceuticals ALNY:US $ -146160000 40.09M
Amgen AMGN:US $ 2319M 190M
Aptinyx Inc APTX:US $ -14290000 2.73M
Biogen BIIB:US $ 1030.1M 12.3M
Biomarin Pharmaceutical BMRN:US $ 13.86M 13.56M
Cytokinetics CYTK:US $ -40611000 4.2M
Dynavax Technologies DVAX:US $ 29.01M 40.65M
Enanta Pharmaceuticals ENTA:US $ -29700000 17.4M
Exelixis EXEL:US $ -4607000 28.9M
Gilead Sciences GILD:US $ 2262M 639M
Gw Pharmaceuticals GWPH:US -21027000 1.78M
Halozyme Therapeutics HALO:US $ 50.74M 26.89M
Intercept Pharmaceuticals ICPT:US $ 511K 29.7M
Intra Cellular Therapies ITCI:US $ -53218690 8.11M
Nektar Therapeutics NKTR:US $ -109392000 1.33M
Neurocrine Biosciences NBIX:US $ 67.8M 36.3M
Pfizer PFE:US $ 6662M 905M
Prothena PRTA:US -32109000 1.8M
Regeneron Pharmaceuticals REGN:US $ 1112.7M 54.3M
Repligen RGEN:US $ 51.46M 10.43M
Sarepta Therapeutics SRPT:US $ -141865000 28.85M
Teva Pharmaceutical TEVA:IT 829M 35M
Ultragenyx Pharmaceutical RARE:US $ -82776000 23.79M
Vertex Pharmaceuticals VRTX:US $ -36.36M 920.29M
Xoma XOMA:US $ -6427000 30.3M
YTE INCY:US $ 155.31M 40.5M
Zogenix ZGNX:US $ -51804000 9.77M